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One-sentence summary: Ligand binding triggers the oligomerization of TNFR1 monomers 
and dimers into trimers and higher-order oligomers. 
Editor’s summary: 
Oligomerizing for optimal activity  
Drugs that prevent the activation of the TNF receptor TNFR1 are of great interest because of 
the many roles of this ligand/receptor pair in pathophysiological processes such as 
inflammation. Karathanasis et al. determined the oligomerization state of TNFR1 by 
quantitatively analyzing single-molecule superresolution microscopy data. TNF stimulation 
triggered the clustering of TNFR1 monomers and dimers into trimers and nonamers. Forms of 
TNFR1 with mutations that impaired basal dimerization or that abolished ligand binding did not 
assemble into higher-order oligomers upon TNF stimulation. These results provide insight 
into the oligomerization states of TNFR1 that must be targeted before and after TNF 
stimulation. 
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Abstract 
Ligand-induced tumor necrosis factor receptor 1 (TNFR1) activation controls NF-ĸB (nuclear 
factor kappa-light-chain-enhancer of activated B-cells) signaling, cell proliferation, 
programmed cell death, and survival, and is crucially involved in inflammation, autoimmune 
disorders, and cancer progression. Despite the relevance of TNFR1 clustering for signaling, 
oligomerization of ligand-free and ligand-activated TNFR1 remains controversial. At present, 
models range from ligand-independent receptor pre-dimerization to ligand-induced 
oligomerization. Here, we used quantitative, single-molecule superresolution microscopy to 
study TNFR1 assembly directly in native cellular settings and at physiological cell surface 
abundance. In the absence of its ligand TNFα, TNFR1 assembled into monomeric and dimeric 
receptor units. Upon binding of TNFα, TNFR1 clustered predominantly into trimers but also 
into higher-order oligomers. A functional mutation in the pre-ligand assembly domain (PLAD) 
of TNFR1 resulted in only monomeric TNFR1, which exhibited impaired ligand binding. In 
contrast, a form of TNFR1 with a mutation in the ligand-binding CRD2 subdomain retained the 
monomer-to-dimer ratio of the unliganded wildtype TNFR1 but exhibited no ligand binding. 




The tumor necrosis factor (TNFα) receptor superfamily (TNFRSF) consists of 29 receptors and 
can be divided into TNFα receptor-associated factor (TRAF)-interacting receptors, death 
receptors (DRs), and decoy receptors, which capture ligands, but do not stimulate intracellular 
signaling pathways, thereby counterbalancing other receptors (1-3). DRs contain intracellular 
death domains (DD) that control cell proliferation, inflammation, pro-survival signaling through 
NF-ĸB) as well as programmed forms of cell death (4). TNFR1 is a prototypical, 55-kD type 1 
transmembrane DR (5). Signaling occurs through indirect recruitment of TNFR1-associated 
death domain protein (TRADD), TRAF2, and the TRAF2-interacting E3 ubiquitin ligases 
cellular inhibitor of apoptosis proteins-1 and -2 (cIAP1/2), resulting in activation of pro-survival 
NF-ĸB responses (5), which are involved in cell proliferation (6) and inflammation (7). 
Furthermore, when IAP activities are compromised, TNFR1 activation may lead to the 
induction of apoptosis or, when caspase-8 is inhibited, possibly necroptosis (8) (9). In 
summary, TNFR1 controls cell survival and programmed cell death pathways (10) and is 
involved in vital processes, such as hematopoiesis (11) and protection from bacterial infections 
(12). Disturbances in TNFα-TNFR1 signaling underlie inflammation (10), autoimmune 
diseases (13), and cancer (14). 
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The intracellular DD of TNFR1 is connected through a flexible transmembrane region to four 
extracellular cysteine-rich domains (CRD1 to CRD4) that each contain six cysteine residues 
by which three disulfide bridges are composed (15). Binding of TNFα to TNFR1 leads to TNFα–
TNFR1 interactions in which TNFR1 molecules bind into the clefts formed between the three 
protomers of a trimer of TNFα. X-ray crystallography studies of several TNFRSF ligands alone 
or in complex with the ectodomain of their receptors suggest the formation of trimeric 
TNFα:TNFR1 complexes (16). This finding is consistent with the requirement of clustering of 
TNFRSF members into larger assemblies for efficient signaling, because the trimeric scaffold 
of TNFα can accommodate three TNFR1 monomers (15). However, it remains less clear how 
TNFR1 clustering is organized, achieved, and maintained in unliganded states and upon ligand 
binding within the native environment, namely the plasma membrane of a mammalian cell. 
 
TNFα interacts with TNFR1 through residues within CRD2 and CRD3 (17). CRD1 is most likely 
not directly involved in ligand binding but seems to stabilize CRD2 and CRD3 for optimal ligand 
binding (18). CRD1 is the most distal CRD from the plasma membrane and accommodates 
the pre-ligand assembly domain (PLAD) (17). The PLAD mediates TNFR1 dimerization even 
in the absence of ligand, and PLAD-PLAD binding affinities are in the micromolar range (19). 
Based on this and other evidence, a two-step model of TNFRSF activation has been proposed 
(20). In the first step, ligand-induced formation of trimeric TNFSF (ligand)-trimeric TNFRSF 
(receptor) complexes occurs. In the second step, these complexes are thought to form 
secondary aggregates that are mediated through PLAD-PLAD interactions between trimeric 
TNFSF-trimeric TNFRSF complexes. How the PLAD mediates ligand-dependent or -
independent TNFR dimerization, trimerization, or even oligomerization and subsequent 
TNFR1 signaling, remains unclear. 
 
Thus far, TNFR1 oligomerization has largely been investigated by biochemical receptor 
crosslinking (17, 21) and/or crystallization experiments (15, 22) in which TNFRSF ectodomains 
are isolated from the native membrane environment. Based on these data, different TNFR1 
oligomerization models were proposed (16, 17, 21, 23). Although these types of study have 
generated much valuable information, it remains unclear how TNFR1 distributions are 
organized in their native environment, the mammalian plasma membrane. Ideally, receptor 
organization into functional units should be observed directly in physiological cellular settings 
to maintain the native membrane environment and to avoid the perturbation of protein-protein 
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interactions that orchestrate receptor oligomerization. Optical microscopy seems the obvious 
tool for such investigations, but has been limited in spatial resolution for a long time. 
Developments in advanced optical microscopy have provided the necessary spatial resolution 
and sensitivity to determine the oligomeric state of a receptor within a protein assembly (24). 
Single-molecule localization microscopy (SMLM) is particularly suited to provide quantitative 
information on protein assembly by exploiting information from a fluorophore-label conjugated 
or bound to a specific receptor (25). Such information may be the kinetics of photoswitching of 
the fluorescent reporters (26, 27) or the binding kinetics of fluorophore labels (28). For 
example, quantitative SMLM has revealed a selective organization of Toll-like receptor 4 
(TLR4) in response to specific bacterial ligands (29). 
 
Here, we used quantitative SMLM (24, 25) in combination with total internal reflection 
fluorescence (TIRF) illumination to interrogate how TNFR1 assembles into functional units or 
clusters on the plasma membrane of a mammalian cell. Specifically, we studied unliganded 
and TNFα–activated TNFR1, together with functional mutants of TNFR1. For this purpose, we 
reconstituted TNFR1/2 double knock-out (-/-) mouse embryonic fibroblasts (MEFs) with 
TNFR1-mEos2 to recapitulate complete cellular TNFR1 functionality. Furthermore, we 




A cellular system to image and quantify TNFR1 clustering using superresolution 
microscopy 
To address how TNFR1 distributions are organized in the plasma membrane, we generated a 
genetic system that enabled quantitative analysis of TNFR1 oligomerization status in the 
plasma membrane of intact cells using superresolution microscopy. For this, TNFR1/2 double 
knockout (-/-) mouse embryonic fibroblasts (MEFs) were transduced with lentivirus to stably 
express full-length human TNFR1, which was fused at the C terminus to the photoactivatable 
fluorescent protein mEos2 (TNFR1/2-/- + TNFR1-mEos2). mEos2 is suitable for 
superresolution PALM imaging (30), and enables the calculation of molecule numbers because 
of its photoblinking properties (26, 27, 29, 31). Previously, we have shown that TNFR1-mEos2 
fusion proteins do not undergo mEos2-induced dimerization (32). The absence of TNFR2 in 
the reconstituted TNFR1/2-/- + TNFR1-mEos2 MEFs enabled analysis without confounding 
factors of TNFR1 clustering and signaling, because it has been reported that in certain 
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scenarios TNFR2 modulates TNFR1 activation (20). Western blotting analysis of total cell 
lysates with anti-TNFR1 antibody revealed the existence of a major band corresponding to the 
molecular mass of TNFR1-mEos2 and several non-specific background bands (Fig. 1A). The 
total amounts of TNFR1 in the reconstituted TNFR1/2-/- + TNFR1-mEos2 MEFs was relatively 
increased compared to TNFR1 levels of the human cervix carcinoma HeLa cell line. The anti-
TNFR1 antibody used here for detection of TNFR1 levels recognizes only human TNFR1 and 
does not cross-react with mouse TNFR1. Furthermore, apart from the major TNFR1 isoform 
1, this antibody also recognizes additional, smaller TNFR1 isoforms. However, these additional 
bands are most likely not involved in ligand binding and TNFR1 clustering, because Flag-
tagged TNFα immunoprecipitation of TNFR1 from HeLa cells and TNFR1-mEos2 from 
TNFR1/2-/- + TNFR1-mEos MEFs only enrich the major TNFR1 bands and not the these 
smaller isoforms (Fig. S1). 
 
TNFR1/2-/- + TNFR1-mEos2 MEFs exhibited normal TNFα-induced NF-ĸB signaling, as 
revealed by examining TNFα-induced IĸBαphosphorylation and subsequent degradation 
patterns, which were similar to those of wild-type (WT) MEFs (upon 3 hours serum-starvation) 
(Fig. 1B). In contrast and as expected, TNFR1/2-/-  MEFs and TNFR1/2-/- MEFs expressing 
mEos2 alone were defective in TNFα-induced NF-ĸB signaling. The NF-ĸB signaling status of 
the TNFR1/2-/- + TNFR1-mEos2 MEFs was further confirmed by immunofluorescence 
microscopy analysis of TNFα-induced p65 nuclear accumulation. Indeed, upon stimulation with 
TNFα, TNFR1/2-/- + TNFR1-mEos2 MEFs were similar to TNFα-treated WT MEFs in terms of 
the extent of nuclear accumulation of p65, confirming that reconstitution of TNFR1/2-/- MEFs 
with TNFR1-mEos2 did not interfere with signal progression (Fig. 1C). In contrast, TNFR1/2-/- 
MEFs did not show nuclear p65 accumulation in response to TNFα (Fig. 1C). 
 
These observations suggest that stable reintroduction of TNFR1-mEos2 into TNFR1/2-/- MEFs 
functionally restored TNFα-induced and TNFR1-mediated NF-ĸB signaling. Furthermore, 
although TNFR1 abundance was greater in TNFR1/2-/- + TNFR1-mEos2 MEFs compared to 
HeLa cells, TNFR1 did not display autoactivation in the absence of TNFα, suggesting 
functional restoration of TNFR1-mediated NF-ĸB signaling to near-endogenous settings (Fig. 
1B, 1C). 
 
We assessed whether reconstitution of TNFR1/2-/- MEFs with TNFR1-mEos2 also restored 
TNFα-induced, TNFR1-mediated programmed cell death.Together, these results confirm the 
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functionality of the reconstituted TNFR1-mEos2 fusion protein in TNFR1/2-/- + TNFR1-mEos2 
MEFs by rescue of TNFR1-dependent, TNFα-mediated signaling events during short- and 
long-term episodes of ligand exposure. 
 
Quantitative PALM imaging of TNFR1 multimerization in the mammalian plasma 
membrane 
To determine the membrane distribution status of TNFR1 in reconstituted TNFR1/2-/- + TNFR1-
mEos2 MEFs, cells were subjected to 24 hours of serum-starvation to reset TNFα-TNFR1 
signaling and PALM imaging to visualize the distribution of single TNFR1-mEos2 clusters with 
sub-diffraction spatial resolution (Fig. 2, A and B). These images were further analyzed to 
determine the number of mEos2 proteins per cluster (and hence, the number of TNFR1-mEos2 
within a cluster), following published procedures (26, 27, 31) that were previously used to 
determine the oligomeric state of Toll-like receptor 4 (29) (Fig. S3A, S3B, S3C and S3D). 
 
Quantitative analysis of serum-starved TNFR1-mEos2 at the plasma membrane of TNFR1/2-/-  
+ TNFR1-mEos2 MEFs revealed a density of 1.4 +/- 0.4 TNFR1-mEos2 clusters/µm² (Table 
1) and an organization of TNFR1-mEos2 into 66 +/- 4 % monomeric and 34 +/- 4 % dimeric 
TNFR1 fractions (Fig. 2C, Table 2 and Table S1). Notably, on the surface of serum-starved 
TNFR1/2-/-  + mEos2 MEFs, trimeric or higher-order TNFR1-mEos2 clusters were not detected. 
 
Next, we determined how exogenously added TNFα alters the TNFR1-mEos2 membrane 
organization and clustering distribution. For this purpose, we used a fully-functional SNAP-
tagged TNFα (SNAP-Flag-TNC-TNFα), which had a binding affinity of 6 +/- 3 ng/ml in a HeLa 
cell-based assay, which is on a similar order of the binding affinity of huTNFα-Flag-TNC-GpL 
with a value of KD = 12 +/- 5 ng/ml (Fig. S4A and S4B), and whose functionality was verified 
by cell survival assays (Fig. S4C). We incubated serum-starved TNFR1/2-/-  + TNFR1-mEos2 
MEFs for 30 min with SNAP-Flag-TNC-TNFα conjugated to Alexa Fluor 647 (TNFα-SNAP-
AF647) at 4 °C to prevent TNFR1 internalization upon ligand binding (34). Applying 
fluorophore-labelled ligand allowed the distinct selection of ligand-bound TNFR1-mEos2 
molecules and quantitative analysis. PALM images of TNFR1/2-/-  + TNFR1-mEos2 MEFs 
treated with TNFα-SNAP-AF647 demonstrated colocalization of a fraction of TNFR1-mEos2 
with TNFα-SNAP-AF647 (Fig. 3, A and B). Quantitative analysis revealed a total TNFR1 
density of 1.6 +/- 0.7 clusters/µm² (Table 1).  
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The blinking histogram (Fig. 3C) was analyzed with a total of 511 different models ranging 
from one to nine components and covering all possible combinations of monomer to 9-mer (9 
models for one component, 36 for two components, 84 for three components, 126 for four 
components, 126 for five components, 83 for six components, 35 for seven components, 9 for 
eight components, and one for nine components). The best model was identified by statistical 
analysis using the Bayesian information criterion.  
TNFα-colocalized TNFR1-mEos2 (yellow circles) organized into 13 +/- 2 % monomers, 64 +/- 
2 % trimers, and a fraction of higher-order oligomers that could best be approximated with the 
distribution function for 9-mers, yielding 23 +/- 3 % (Fig. 3C, Table 2 and Table S2). In 
contrast, the ligand-free TNFR1-mEos2 population upon TNFα-SNAP-AF647 incubation was 
detected in a 41 +/- 4 % monomer and 59 +/- 4 % dimer distribution (Fig. 3D, Table 2 and 
Table S3). 
 
Thus, we could demonstrate that in unliganded TNFR1/2-/- + TNFR1-mEos2 MEFs, TNFR1-
mEos2 adopted a monomer/dimer distribution, and that upon ligand binding, TNFR1-mEos2 
predominantly organized into trimers and higher order oligomers with only a small fraction of 
monomers left. Ligand-free monomeric TNFR1-mEos2 also shifted into a dimeric TNFR1-
mEos2 population upon ligand incubation. These findings indeed support a model of a dynamic 
equilibrium of monomeric and dimeric TNFR1 in the membrane which redistribute into trimers 
and higher order oligomers after ligand binding (20). 
 
 
Quantitative PALM of TNFR1 with mutations in the PLAD or ligand binding site  
To understand the role of the TNFR1 PLAD in TNFR1-mEos2 dimerization, higher-order 
clustering and global membrane distribution patterns, a K32A point mutation was generated in 
TNFR1-mEos2 CRD1 which is located in the predicted PLAD of TNFR1 and which abrogates 
self-assembly (17). Quantifying TNFR1-mEos2 K32A distribution in serum-starved TNFR1/2-/- 
+ TNFR1-mEos2 K32A MEFs revealed the presence of only monomeric TNFR1 on the plasma 
membrane (Fig. 4A, Table 2 and Table S4). We observed only a low amount of specific 
binding of TNFα-SNAP-AF647 to TNFR1/2-/- + TNFR1-mEos2 K32A MEFs (Fig. 4B and Table 
S5) (KD = 91 +/- 33 ng/ml compared to KD = 16 +/- 3 ng/ml of WT TNFR1-mEos2 (Fig. S2B)). 
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In contrast, the TNFR1 CRD2 mutation N66F, which is located in the ligand binding site, 
displayed a 54 +/- 3 % monomeric and 46 +/- 3 % dimeric distribution in TNFR1/2-/-  + TNFR1-
mEos2 N66F MEFs (Fig. 4C, Table 2 and Table S6). As expected, we did not observe any 
ligand binding to TNFR1/2-/-  + TNFR1-mEos2 N66F MEFs (Fig. 4D and Table S7). These 
results suggest that a functional PLAD is essential to generate the fraction of ligand-
independent dimeric TNFR1 at the mammalian plasma membrane and that TNFα-binding site 
mutations do not interfere with ligand-independent PLAD-mediated TNFR1 clustering. 
 
However, it must be noted that both TNFR1 K32A and N66F were found at lower amounts in 
total cell lysates (Fig. 4E) compared to WT TNFR1, which was confirmed by FACS analysis 
(Fig. S2A). In PALM experiments, only a small number of cells was found with a sufficiently 
high abundance of TNFR1 for imaging and analysis, which might have led to an experimental 
bias. Apparently, the K32A and N66F mutations in TNFR1-mEos2 might affect protein stability, 
localization, or inter-organelle TNFR1 transport, which has been reported for several TNFR1 
PLAD mutations observed in TNF Receptor Associated Periodic Syndrome (TRAPS), a rare 
genetic autoinflammatory disorder (35). It is possible that mutated TNFR1-mEos2 fails to fold 
properly and therefore can no longer be anchored in the membrane, thereby affecting PALM 
imaging because this method detects intracellular, membrane-proximal TNFR1-mEos2 (TIRF 
illumination). TNF binding studies indicate that TNFR1 -mEos2 K32A still binds to ligand, while 
this binding was lost for TNFR1-mEos2 N66F (Fig. S2B). PALM imaging and quantitative 
analysis of cells with a sufficient abundance of receptors and exposed to TNFα-SNAP-AF647 
revealed a monomeric TNFR1 (for the K32A mutant) and a mixture of monomers and dimers 
(for the N66F mutant) (Fig. 4C, 4D). In addition, both TNFR1-mEos2 K32A and N66F, display 
suppressed NF-B activation measured through IĸBα phosphorylation and degradation by 




Multimeric clustering of TNFR1 is essential for survival and cell fate signaling and mediates 
activation of the NF-ĸB pathway. The spatial organization of TNFR1 in ligand-free and ligand-
bound states in the physiological membrane environment remains, however, largely unclear. 
Here, we studied TNFR1 distribution into different states of multimerization in unliganded and 
TNFα-treated cells. To monitor the TNFR1 clustering distribution by PALM, we reconstituted 
TNFR1/2-/- MEFs with full-length human TNFR1-mEos2. mEos2 is a ~ 26-kDa photoactivatable 
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protein that was fused to the C-terminus of TNFR1. Although the C-terminally located death 
domain of TNFR1 is essential for triggering TNFR1-mediated NF-ĸB and cell death signaling, 
C-terminal fusion of mEos2 did not substantially interfere with TNFR1-mediated functions. 
Stable expression of TNFR1-mEos2 in TNFR1/2-/- MEFs completely restored TNFα-induced 
IĸBα phosphorylation and degradation as well as the induction of programmed forms of cell 
death mediated through TNFR1. In sum, these data suggest functional TNFR1 signaling in 
TNFR1-mEos2 reconstituted TNFR1/2-/- MEFs. 
 
We next applied quantitative PALM to determine the molecular distribution of TNFR1-mEos2 
in the plasma membrane. Our data revealed that 66% of TNFR1-mEos2 was monomeric and 
34% was dimeric in the absence of ligand. These observations suggest that low-affinity TNFR1 
PLAD-PLAD interactions primarily mediate the formation of TNFR1 dimers, which are likely to 
exist in a dynamic equilibrium with monomeric TNFR1 (20). Indeed, this notion is supported by 
the almost exclusive monomeric distribution of the PLAD mutant TNFR1-mEos2 K32A (Fig. 
4A). 
 
Upon ligand binding, most of the TNFR1-mEos2 molecules became organized into trimeric 
receptor clusters, as well as higher-order clusters that could be extracted using a single 
additional function for a 9-mer to fit the experimental data of fluorophore blinking (31). 
Formation of TNFR1 9-mers could potentially be organized by PLAD-PLAD–mediated 
interactions of ligand-bound TNFR1 trimers. 
 
The affinity of TNFα for the PLAD mutant TNFR1-mEos2 K32A was approximately 5-fold less 
than that for WT TNFR1-mEos2 (Fig. S2B) but was still high enough to substantially occupy 
TNFR1-mEos2 K32A at the concentration of 100 ng/µl used for functional PALM imaging (Fig. 
4B). Nevertheless, TNFα was not only unable to trigger formation of TNFR1 trimers and 
nonamers, but also completely failed to elicit an NF-ĸB response. This finding initially 
suggested that ligand-bound TNFR1 trimers and nonamers are the signaling active species. 
However, chimeric death receptors, in which the extracellular domain of TNFR1 has been 
replaced by TNFR2 or CD95, bind to soluble TNFα and CD95L, respectively, but are not 
activated by these ligands (36). Instead, strong signaling is initiated from these chimeric 
receptors when oligomerized ligand trimers are used for stimulation. The binding of soluble 
TNFα and soluble CD95L to three molecules of TNFR2 and CD95, respectively, suggests that 
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two or more trimeric TNFα receptor complexes are required for proper receptor engagement. 
Therefore, it seems likely that liganded nonameric TNFR1 species are the major and dominant 
signaling active TNFR1 fraction. A careful selection of fitting parameters, together with the 
evaluation of different possible models through their fitting quality, enabled us to conclude that 
TNFα-activated TNFR1-mEos2 mainly organizes into trimers and likely 9-mers, whereas 
tetramers or pentamers are less likely to occur in the membrane. Although this does not 
exclude PLAD-PLAD-mediated interactions of two ligand-bound TNFR1 trimers, we only see 
a low probability for the presence of 6-mers as intermediate scaffold. 
 
Although we used a concentration of 100 ng/ml TNFα which saturates TNFR1 (Fig. S2B), we 
detected only about 20 +/- 9 % TNFR1 clusters bound to TNFα in PALM images. We believe 
that this is in part due to our imaging and detection window (TIRF illumination), which extends 
about 100 to 200 nm deep into the cell. We cannot exclude that we also detected intracellular 
TNFR1, such that receptor densities determined from PALM images (Table 1) might not only 
represent TNFR1 on the cell membrane, but also TNFR1 present in the Golgi network, an 
organelle known to be involved in TNFR1 trafficking and recycling (37, 38). The ligand-bound 
TNFR1 density in TNFR1/2-/- - + TNFR1-mEos2 MEFs was 0.3 +/- 0.1 clusters/µm². 
Considering a mean surface of TNFR1/2-/- + TNFR1-mEos2 cells of 2539 +/- 608 µm², this 
translates into 762 +/- 182 TNFR1-TNFα complexes per cell (Fig. 3A, 3B, Table 1). 
Considering that there are 13 % monomeric, 64 % trimeric and 23 % nonameric TNFR1 in 
TNFα-activated cells, this suggests a total number of 3139 +/- 750 TNFR1 molecules per cell. 
These data are consistent with TNFR1 copy numbers per cell as determined by luciferase 
assay, which reported 2698 +/- 2518 copies of TNFR1 (Fig. S2B).  
 
In sum, our data support a model of TNFR1 activation by soluble TNFα in which the PLAD-
PLAD interaction not only facilitates TNFα binding by the formation of dimeric TNFR1 species 
in the plasma membrane with higher affinity for TNFα, but is also required for clustering of 
inactive or poorly active liganded TNFR1 trimers into signaling active higher-order clusters 
(Fig. 5). Our statistical analysis of single-molecule superresolution data indicates that these 
higher-order clusters are likely to be nonamers. It is tempting to speculate that the strength of 
the PLAD-based auto-affinity of TNFRSF receptors determines whether clustering to signaling 
competent receptor nonamers or oligomers occurs spontaneously after binding of soluble 
ligand trimers due to sufficient PLAD-PLAD auto-affinity (as in the case of TNFR1) or whether 
this requires stimulation with physically linked soluble ligand trimers (as in the case of TNFR2 
or CD95) due to a too low auto-affinity. Our work furthermore demonstrates that advanced 
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superresolution microscopy together with quantitative analysis can extract the oligomeric state 
of unliganded and ligand-bound receptors of the TNFRSF directly in its native environment, 




Materials and Methods 
Cell lines, reagents, and antibodies 
Immortalized Tumor Necrosis Factor Receptor (TNFR) 1/2 knock-out (-/-) mouse embryonic 
fibroblasts (MEFs) were obtained from Daniela Männel (Regensburg) and maintained in 
Roswell Park Memorial Institute (RPMI) medium (ThermoScientific), supplemented with 10 % 
fetal bovine serum (FBS) (Gibco), 1 % Glutamax (Thermo Scientific), 1 % 
Penicillin/Streptomycin (Life Technologies, Inc.), at 37 ºC with 5 % CO2. Human cervical 
carcinoma cells (HeLa) and human embryonic kidney (HEK) 293T Phoenix-ECO Ecotropic 
packaging cells were obtained from and authenticated by the American Type Culture 
Collection (ATCC). HeLa and Phoenix-ECO 293Ts were maintained in Dulbecco’s Modified 
Eagles Medium (DMEM), supplemented with 10 % FBS, 1 % Penicillin/Streptomycin and 1 % 
sodium pyruvate (Life Technologies, Inc.), at 37 ºC with 5 % CO2. All cell lines were regularly 
monitored for Mycoplasma infection. Recombinant human TNF was purchased from 
Peprotech and Biochrom, BV6 was a kind gift from Domagoj Vucic (Genentech, Inc), and 
zVAD.fmk was purchased from Bachem. All other chemicals were obtained from Sigma-Aldrich 
or Carl Roth, unless indicated otherwise. Antibodies used were monoclonal mouse anti-human 
vinculin (V9131, Sigma), anti-human IĸBα (#9242, Cell Signalling Technology), anti-phospho-
IĸBα (Ser32, 14D4, 2859, Cell Signalling), anti-NF-ĸB p65 (C-20, sc-372, Santa Cruz 
Biotechnology), mouse anti-TNFR1 H-5 (sc-8436, Santa Cruz), rabbit anti-TNFR1 C25C1 (# 
3736S, Cell Signalling). We note that anti-TNFR1 C25C1 also targets a truncated isoform of 
TNFR1 in some cell lines, as reported by the company. 
 
DNA cloning, virus production, and viral transduction 
Template plasmids encoding full-length human TNFR1 (TNFRSF1A, Uniprot P19438) and 
monomeric Eos2 (mEos2) were described previously (39). The pBABE-puro retroviral vector 
was obtained from Addgene (plasmid # 1764). Genetic C-terminally tagged TNFR1-mEos2 
fusions were generated using standard cloning PCR, with a 5’ Kozak sequence for translation 
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initiation and a 3’ stop codon and lacking the signal peptide residues 1 – 29, using conventional 
restriction digest cloning. Cloning details and primer sequences are available upon request. 
Clones were verified with Sanger DNA sequencing. To generate high-titer viral particles, 
Phoenix-ECO 293T helper cells were seeded at a density of 7.5 x 105 cells per well in six-well 
plates (Greiner), 24 hours before transfection in DMEM without antibiotics. Transfections with 
pBABE-puro, pBABE-puro-mEos2 and wild-type, K32A and N66F pBABE-puro-TNFR1-
mEos2 were performed with FuGENE HD Transfection Reagent (Promega), according to the 
manufacturer’s instructions in serum-reduced OptiMEM (Thermo Scientific). Medium was 
replaced with DMEM with serum and antibiotics at 12 hours post-transfection and viral 
supernatants were collected 48 and 72 hours later. Supernatants were pooled, briefly 
centrifuged and frozen for storage at -80 ºC. Viral supernatants were thawed, filtered through 
0.45-µm filter units, and mixed with 10 µg/ml Polybrene to infect 5 x 105 TNFR1/2-/- MEFs 
overnight at 37 ºC in complete RPMI. Stably transduced cells were selected in complete RPMI 
with puromycin (2 µg/ml). Single clones were isolated and evaluated for TNFR1 expression by 
Western blotting. 
 
Cell lysis and Western blotting 
Cells were washed twice with ice-cold Phosphate-Buffered Saline (PBS) (Gibco) and lysed in 
lysis buffer (30 mM Tris-HCl pH 7.4, 150 mM NaCl, 1 % (v/v) Triton X-100 and 10 % (v/v) 
glycerol), supplemented with Complete Protease Inhibitors (Roche). Lysates were incubated 
on ice for 20 min. and centrifuged at 16.060 g at 4 ºC for 20 min. Cleared cell lysates were 
boiled in 2 x Laemmli Sample Buffer (4 % (w/v) SDS, 20 % (v/v) glycerol, 120 mM Tris-HCl pH 
6.8, 0.02 % bromophenol blue) and resolved on SDS-PAGE followed by immunoblotting and 
detection with goat anti-mouse IgG or goat anti-Rabbit IgG conjugated to horseradish 
peroxidase (HRP) (Santa Cruz) and enhanced chemiluminescence (Amersham).  
 
Cytokine stimulation 
The indicated stably reconstituted TNFR1/2-/- MEFs, WT MEFs and HeLa cells were seeded 
in six-well plates (Greiner) at a density of 7.5 x 105 cells per well 24 hours prior to stimulation 
in RPMI with FBS and antibiotics. Cells were serum-starved in RPMI without FBS for 3 hours 
at 37 ºC and subjected to a single-dose of human recombinant TNFα in serum-free RPMI at 
the indicated concentrations for the indicated time points at 37 ºC. After cytokine stimulation, 
medium was removed and cells were processed for further analysis. 
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Immunofluorescence 
WT, TNFR1/2-/- and stably reconstituted TNFR1-mEos2 TNFR1/2-/- MEFs were seeded on 
sterile cover slips in six-well dishes (Greiner) at a density of 7.5 x 105 cells per well 24 prior to 
stimulation in RPMI with FBS and antibiotics. Cells were serum-starved in RPMI without FBS 
for 3 hours at 37 ºC and subjected to a single-dose of human recombinant TNFαin serum-free 
RPMI at the indicated concentrations for the indicated times at 37 ºC. Medium was removed 
and the cells were washed with PBS and fixed in 4 % paraformaldehyde (Santa Cruz) in PBS 
for 20 min at room temperature. Cells were washed three times with PBS and permeabilized 
with 0.2 % Triton-X100 in PBS for 5 min at room temperature. Cells were washed again three 
times with PBS and blocked with 5 % bovine serum albumin (BSA, Roth) in PBS overnight at 
4 °C. Cells were incubated with anti-p65 antibody diluted in 5 % BSA in PBS for 4 hours at 
room temperature. Cells were subsequently washed three times with 0.1 % Tween-20 in PBS 
and incubated with Alexa Fluor 647-labeled secondary antibodies in 5 % BSA/PBS. Cells were 
washed with 5 % BSA/PBS three times, nuclei were counterstained with DAPI (Molecular 
Probes) and samples were mounted in aqueous mounting medium (ProLong Antifade Gold, 
Thermo Fischer Scientific) on macroscopic glass supports. Images were acquired on a Leica 
SP8 confocal laser-scanning microscope (Leica). 
 
Determination of cell death 
Cell lines were seeded at a density of 0.6 x 104 cells / well in sterile 96-well plate (Greiner) in 
complete medium 24 hours prior to cell death induction. Cells were pretreated with 10 μM BV6 
alone (to induce extrinsic apoptosis) or combined with 20 μM zVAD.fmk (to induce necroptosis) 
for 1 hour at 37 °C. Human recombinant TNFα (10 ng/ml) was then added and the cells were 
incubated for 24 hours at 37 °C. Cell death was measured by fluorescence-based microscope 
quantification of propidium iodide (PI) uptake using Hoechst 33342 and PI double staining 
(Sigma-Aldrich) using the ImageXpress Micro XLS Widefield High-Content Analysis System 
and MetaXpress software according to the manufacturer's instructions (Molecular Devices 
Sunnyvale). 
 
Fluorescence-activated cell sorting analysis 
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To analyze TNFR1 cell surface expression, 5 x 105 of the indicated MEFs were washed twice 
with PBS and incubated for 30 min. at 4 °C with αTNFR1-PE (#FAB225P; R&D) and 
corresponding mIgG1-PE (#IC002P; R&D) isotype control. To remove unbound antibodies, 
cells were washed again twice with PBS and analyzed with FACS-Calibur (BD Bioscience), 
following standard procedures. 
 
Cellular binding studies 
 
Binding affinities of huTNFα-F-TNC-GpL to TNFR1 were determined by cellular equilibrium 
binding studies. Therefore, aliquots of the indicated cells (4 x 105) were challenged with 
increasing concentrations of the TNFα-GpL-fusion protein (to measure total binding). Values 
for nonspecific binding were derived for HeLa cells by blocking TNFR1 with 20 µg/ml 
recombinant human TNFα and for MEFs with TNFR1-deficient MEFs. After 1.5 h at 37 °C, 
unbound TNFα-GpL-fusion protein was removed by washing the cells three times with ice cold 
PBS. Finally, cells were resuspended in 50 µl RPMI 1640 media supplemented with 0.5 % 
FCS and transferred to a black 96-well plate. GpL-activity was measured with the Gaussia 
luciferase assay kit (New England Biolabs GmbH) and the LUmo Luminometer (Anthos Labtec 
Instruments). Specific binding values were calculated by subtracting the unspecific binding 
from total binding. To analyze the cellular binding affinity of SNAP-F-TNC-TNFα to TNFR1, 
homologous competition experiments were performed with aliquots of 4 x 105 HeLa cells 
incubated at 37C simultaneously with increasing concentrations of SNAP-F-TNC-TNFαand a 
constant amount of huTNFα-F-TNC-GpL (2.5 ng/ml). After 1.5 hours, the cells were washed 
three times with ice-cold PBS, and GpL-activity was measured as described earlier. Binding 
curves were analyzed by fitting the data with a Hil1 function implemented in OriginPro 2019 
(Equation 1). 




          (𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 1)  
𝐼𝑛𝑡(0) and 𝐼𝑛𝑡(𝑠𝑎𝑡) indicate the lowest and largest values of measured intensity, respectively; 
𝑐 is the corresponding concentration of TNFα; 𝑛 is the number of cooperative sites; and 𝐾𝐷
𝑛 is 
the dissociation constant. To define the number of huTNFα-F-TNC-GpL binding sites per cell 
(NBS) and thus the number of TNFR1 molecules per cell, the luciferase activity of a defined 
amount of huTNFα-F-TNC-GpL molecules was measured to determine the luciferase activity 
per GpL-domain (AGpL-domain). Additionally, the maximal specific binding (Bmax) of the 
corresponding cellular binding studies were obtained by fitting the data with the one-site 
specific binding function of GraphPad Prism 5. Together with the counted cell numbers (CN), 
the number of TNFR1 molecules was calculated with equation 2. 




          (𝐸𝑞𝑢𝑎𝑡𝑖𝑜𝑛 2) 
Cross-linking of FLAG M2 antibody to Protein G Dynabeads 
To crosslink the FLAG M2 antibody to magnetic beads, 25 μl Protein G Dynabead slurry 
(ThermoFisher) was washed three times with 0.05% Tween-20/PBS, then incubated with 4 μg 
FLAG M2 monoclonal antibody (Sigma) for 2 h at 4 °C. Beads were washed in 0.2 M 
triethanolamine (TAE) in PBS, incubated with 20 mM dimethyl pimelimidate (DMP; Sigma) in 
0.2 M TAE pH 8.2 for 30 min at room temperature, and quenched with 50 mM Tris-HCl pH 7.5 
and three washes with 0.05% Tween-20/PBS. 
 
FLAG-TNFα immunoprecipitation of TNFR1 
The indicated cell lines were seeded in sterile 10-cm2 dishes in complete medium at a density 
of 1.0 x 106 cells/plate. After 24 h, cells were serum-starved for 24 h and incubated with FLAG-
tagged TNFα (Enzo Life Sciences) at 1 μg/ml at 4° C in serum-free medium for 30 min. Cells 
were washed twice with ice-cold PBS and lysed in lysis buffer (30 mM Tris-HCl pH 7.4, 150 
mM NaCl, 1 % (v/v) Triton X-100 and 10 % (v/v) glycerol), supplemented with Complete 
Protease Inhibitors (Roche). Lysates were incubated on ice for 20 min. and centrifuged at 
16.060 g at 4 ºC for 20 min. Cleared lysates were incubated with DMP-cross-linked Protein G 
magnetic Dynabeads for 24 h at 4 °C and washed three times with lysis buffer. 
Immunoprecipitates were boiled in 2 x Laemmli Sample Buffer (4 % (w/v) SDS, 20 % (v/v) 
glycerol, 120 mM Tris-HCl pH 6.8, 0.02 % bromophenolblue) and resolved by SDS-PAGE.  
Immunoprecipitated proteins were detected by immunoblotting with the appropriate antibodies 
and goat anti-mouse IgG or goat anti-Rabbit IgG conjugated to horseradish peroxidase (HRP) 
(Santa Cruz) and by enhanced chemiluminescence (Amersham). 
Sample preparation for PALM imaging 
The homotrimeric SNAP-Flag-TNC-TNFα was labelled with a 2-fold excess of Alexa Fluor-647 
benzylguanine (NEB) in PBS (note that the homotrimer contains three SNAP subunits, which 
ensures efficient labeling of the homotrimer with at least one fluorophore). For cell seeding, 8-
well flexiPERM reusable slides (Sarstedt) mounted on glass slides (Thermo Scientific) were 
washed in isopropyl alcohol (Merck) for 15 min and plasma-cleaned in N2 for 15 min (Diener 
Electronic) to reduce background. The cleaned slides were coated for 90 min with 0.8 mg/ml 
Poly-L-Lysine (PLL) (Merck) coupled to polyethylene glycol (PEG) (Rapp Polymere) and a 
peptide containing the RGD motif (PLL-PEG-RGD) to facilitate cell adhesion. For TNFR1-
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mEos2 SMLM, 1.5 x 104 TNFR1/2-/- MEFs stably reconstituted with TNFR1-mEos2 WT, 
TNFR1 K32A or TNFR1 N66F were seeded in 300 µl/well serum-free RPMI Medium (Thermo 
Scientific), 1 % glutamax (Thermo Scientific), 100 U/ml penicillin (Thermo Scientific), 100 µg/ml 
streptomycin (Thermo Scientific) and 50 µg/ml gentamycin (Thermo Scientific). After 24 h of 
starvation, seeded cells were induced with 100 ng/ml (2.4 nM) SNAP-Flag-TNC-TNFα labelled 
with Alexa Fluor 647 in ice-cold serum-free medium at 4 °C for 30 min. Cells were washed 
three times with 300 µl of 400 mM sucrose (Sigma), dissolved in sterile filtered phosphate 
buffered saline (PBS) (Thermo Scientific) and fixed in 300 µl 4 % formaldehyde (Thermo 
Scientific, ), 0.1 % glutaraldehyde (Merck) and 400 mM sucrose in sterile filtered PBS. After 
fixation, cells were washed three times with sterile filtered PBS. 
 
Single-molecule localization microscopy (SMLM) 
SMLM imaging (PALM) was performed on a custom-built microscope that was essentially 
described previously (27). The microscope is equipped with three laser modules emitting at 
638 nm (LBX-638-180, Oxxius, 4.6 Wcm-²), 568 nm (Sapphire 568 LP, Coherent; 0.21 kWcm-
²) and 405 nm (LBX-405-50-CSB-PP, Oxxius; 0-8.0 mWcm-²). The laser lines were combined 
with appropriate dichroic mirrors (AHF) and directed onto a 100 x oil immersion objective 
(PLAPO 100x TIRFM, NA ≥ 1.45, Olympus) mounted on an inverted microscope (IX71, 
Olympus). A movable mirror enabled repositioning of the laser beam to achieve total internal 
reflection fluorescence (TIRF). Fluorescence light that had passed through the appropriate 
filters (ET 700/75 for Alexa Fluor 647, Brightline HC 590/20 for mEos2; AHF) was detected 
with an EMCCD camera (iXon Ultra (X-10971), Andor), operated at an integration time of 100 
ms, a pre-amplifier gain of 1, and an electron multiplying gain of 200. Single-molecule movies 
were recorded between 50,000 and 100,000 frames until no further blinking events were 
detected. An average localization precision of 14 +/- 1.4 nm was determined from a 
representative set of 62 images using a nearest-neighbor approach (40). The cell surface of 
100 TNFR1/2-/- + TNFR1-mEos2 cells was determined from bright light images and quantitative 
analysis with Fiji (41). 
 
Quantitative image analysis 
Superresolved images were generated from PALM data using rapidSTORM (42) and post-
processed with LAMA (43). Quantitative analysis of TNFR1 clustering was performed with a 
method developed and applied previously (27, 29, 31). Briefly, the number of emission events 
was determined for each cluster in the superresolved image (Fig. S3A), applying a threshold 
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of 63 photons. Photon numbers per single-molecule detection event were obtained by 
converting electron counts of the EMCCD with a camera-specific correction factor. Signals 
from mEos2, which appeared in consecutive camera frames within a radius of 90 nm, were 
grouped together as a single localization by a Kalman-filtering algorithm implemented in 
rapidSTORM. For the determination of the oligomeric state, the number of blinking events of 
> 500 single superresolved clusters per condition were plotted and fitted with appropriate 
functions as described previously (31). Clusters with low brightness, a diameter >150 nm, low 
circularity, or in close vicinity to neighboring clusters (distance of <100 nm) were discarded 
from the analysis. For each experimental condition, at least 10 cells from at least three 
independent experiments were analyzed. Experimental PALM data (Figs. 2C, 3D, 4A, 4B, 4C 
and 4D) were fit with all possible combinations of model functions, including monomer, dimer, 
and trimer (31), resulting in seven different possibilities to analyze the data. These were three 
possibilities for a single component (monomer, dimer and trimer); three possibilities for two 
components (monomer/dimer, monomer/trimer and dimer/trimer); and one possibility for three 
components (monomer/dimer/trimer). The fit quality and the appropriateness of the number of 
free parameters were assessed using the Bayesian information criterion (BIC). For an in-depth 
discussion of the application of the BIC in the quantification of protein oligomers in mixed 
populations, refer to Hummer et al. (31).  
 
Supplementary Materials (see “Supplementary Materials list” below) 
Fig. S1. TNFR1 immunoprecipitations with Flag-tagged TNFα reveal the predominant ligand-
interacting TNFR1 isoforms. 
Fig. S2. Analysis of TNFα/TNFR1-mEos2 binding in MEFs by flow cytometry and TNFα binding 
assays. 
Fig. S3. The concept of quantitative single-molecule localization microscopy. 
Fig. S4. Functional characterization of SNAP-Flag-TNC-TNFα. 
Table S1. Statistical analysis of qPALM data for unliganded WT TNFR1. 
Table S2. Statistical analysis of qPALM data for stimulated WT TNFR1 that colocalized with 
TNF. 
Table S3. Statistical analysis of qPALM data for stimulated WT TNFR1 that did not colocalize 
with TNF. 
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Table S4. Statistical analysis of qPALM data for unliganded TNFR1 K32A. 
Table S5. Statistical analysis of qPALM data for stimulated TNFR1 K32A. 
Table S6. Statistical analysis of qPALM data for unliganded TNFR1 N66F. 
Table S7. Statistical analysis of qPALM data for stimulated TNFR1 N66F. 
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Figure Legends 
Fig. 1. Stable reconstitution of TNFR1/2-/- MEFs with TNFR1-mEos2 rescues TNFα-
dependent and TNFR-mediated NF-ĸB signaling. (A) Cell lysates of TNFR1/2+/+ and 
TNFR1/2-/- MEFs alone or reconstituted with TNFR1-mEos2 were analyzed by Western 
blotting with antibodies against TNFR1 and vinculin as a loading control. Asterisks indicate 
nonspecific bands. HeLa cell extracts were analyzed as positive controls. Western blots are 
representative of three independent experiments. (B) TNFα-induced TNFR1 activation at the 
indicated times in the indicated MEFs was evaluated by Western blotting analysis of the 
phosphorylation and degradation of IĸBα. Vinculin was used as a loading control. Western 
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blots are representative of three independent experiments. (C) TNFα-induced nuclear 
translocation of p65in the indicated MEFs was analyzed by immunofluorescence staining of 
p65. DNA was counterstained by DAPI. Right: Panels show the mEos2 fluorescence signal. 
Scale bars: 10 µm. Images are representative of three independent experiments. (D) 
Evaluation of TNFα-induced programmed cell death. The indicated MEFs were left untreated 
(-) or were treated with TNFα (10 ng/ml) (T) and 20 μM zVAD.fmk (Z) for 48 hours after 30-min 
pretreatment with 10 μM BV6 (B). The percentage of propidium iodide (PI)–positive cells of the 
total cell number was quantified as a measure for cell death. EV, empty vector. Data are means 
± SD of at least three experiments performed in triplicate. ***P < 0.001. 
Fig. 2. Quantitative superresolution microscopy reveals the oligomeric state of 
unliganded TNFR1 in TNFR1/2-/- + TNFR1-mEos2 MEFs. (A) PALM image of unliganded 
TNFR1/2-/-+ TNFR1-mEos2 MEFs. Image is representative of 10 cells in three independent 
experiments. (B) Magnified view of the boxed region in (A). (C) The oligomeric state was 
determined by analyzing the single-molecule blinking signatures of mEos2 (histogram). PDB: 
1NCF, 1TNF. Scale bars: 5 µm (bright light), 2 µm (A), 1 µm (B). 
Fig. 3. Quantitative superresolution microscopy reveals the oligomeric state of 
activated TNFR1 in TNFR1/2-/- + TNFR1-mEos2. (A) PALM image of a TNFR1/2-/- + TNFR1-
mEos2 cell with TNFα-activated TNFR1 (TNFα-SNAP-Alexa Fluor 647).  Image is 
representative of 14 cells in three independent experiments. (B) Magnified view of the boxed 
region in (A), indicating ligand-free TNFR1 (green circles) and ligand-bound TNFR1 (orange 
circles). (C) The oligomeric states of ligand-bound TNFR1 (orange circles in (B)) were 
determined by analyzing single-molecule blinking signatures of mEos2 (histogram). PDB: 
1NCF, 1TNF. (D) The oligomeric state of ligand-free TNFR1 (green circles in (B)) was 
determined by analyzing single-molecule blinking signatures of mEos2. Scale bars: 5 µm 
(bright light), 2 µm (A), 1 µm (B). 
 
Fig. 4. Quantitative superresolution microscopy of TNFR1 carrying mutations in the 
PLAD or ligand-binding domain in TNFR1/2-/- + TNFR1-mEos2 MEFs. (A and B) PALM 
images of TNFR1/2-/- + TNFR1-mEos2 MEFs with TNFR1 carrying a mutation in the PLAD 
(K32A), untreated cells (A) and cells treated with TNF (B). Images are representative of 10 
cells in three independent experiments. The oligomeric states of TNFR1 K32A mutant were 
determined by analyzing single-molecule blinking signatures of mEos2 (histogram). (C and D) 
PALM images of TNFR1/2-/- + TNFR1-mEos2 MEFs with TNFR1 carrying a mutation in the 
ligand-binding domain (N66F), either untreated (C) or treated with TNFα (D). Images are 
representative of 10 cells in three independent experiments. The oligomeric state of TNFR1 
N66F mutant were determined by analyzing single-molecule blinking signatures of mEos2 
24 / 30 
(histogram). PDB: 1NCF. Scale bars: 5 µm (bright light), 2 µm (A-D). (E) Western blot analysis 
of total cell lysates of the indicated TNFR1/2-/- + TNFR1-mEos2 MEFs, probed with anti-
TNFR1. Vinculin was used as a loading control. Asterisks indicate background bands. Western 
blots are representative of three independent experiments.   (F) Evaluation of NF-ĸB 
functionality in the indicated MEFs by assessing TNFα-induced IĸBα phosphorylation and 
degradation. Western blots are representative of three independent experiments. Vinculin was 
used as a loading control 
 
Fig. 5. A molecular model for TNFR1 activation in TNFR1/2-/- + TNFR1-mEos2. Unliganded 
TNFR1 resides in an equilibrium of monomeric and dimeric receptors, with the PLAD as the 
determinant for dimerization. The presence of dimers is crucial for TNFα-induced activation of 
TNFR1, which occurs through the formation of trimeric and higher orders of TNFR1. Mutations 
in the PLAD prevents the formation of dimers (PDB: 1NCF, 1TNF). 
 
 
Table 1. Cluster per µm² and radii determined by PALM. For WT TNFR1, TNFR1 K32A and 
TNFR1 N66F, the number of cluster per µm² and the radii are given. 
Condition Cluster/µm² Radius [nm] 
TNFR-mEos2 WT   
-TNFα
+TNFα
1.4 +/- 0.4 
1.6 +/- 0.7 
17 +/- 13 
19 +/- 4 
TNFR1-mEos2 K32A   
-TNFα 0.2 +/- 0.1 16 +/- 10 
+TNFα 0.3 +/- 0.2 15 +/- 5 
TNFR1-mEos2 N66F   
-TNFα 0.5 +/- 0.2 16 +/- 9 
+TNFα 0.6 +/- 0.4 17 +/- 10 
 
Table 2. Quantitative analysis of TNFR1 clustering as determined by PALM. The 
oligomeric state of receptor clusters (M = monomer, D = dimer, T = trimer) is given for WT 
TNFR1-mEos2, TNFR1-mEos2 K32A and TNFR1-mEos2 N66F. 
Condition Oligomeric state 
TNFR1-mEos2 WT  
-TNFα 66 +/- 4 % (M), 34 +/- 4 % (D) 
25 / 30 
+TNFα (only TNFR1 clusters co localizing with 
TNFα were analysed) 
13 +/- 2 % (M), 64 +/- 2 % (T), 23+/- 3 % (9mer) 
+TNFα (only TNFR1 clusters not co localizing 
with TNFα were analysed) 
41 +/- 4 % (M), 59 +/- 4 % (D) 
TNFR1-mEos2 K32A  
-TNFα 100 +/- 3 % (M) 
+TNFα(all TNFR1 clusters analysed) 100 +/- 3 % (M) 
TNFR1-mEos2 N66F  
-TNFα 54 +/- 3 % (M), 46 +/- 3 % (D) 
+TNFα (all TNFR1 clusters analysed) 56 +/- 3 % (M), 44 +/- 3 % (D) 
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